Gyre Therapeutics Announces NMPA Approval for Clinical Trial Evaluating Pirfenidone Capsules in Oncology-Related Pulmonary Complications
In accordance with the NMPA approval, Gyre intends to pursue an adaptive Phase 2/3 clinical trial design, combining dose exploration with efficacy confirmation, to efficiently evaluate pirfenidone's ...
Le Lézard19m
BrainStorm Cell Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the fiscal year ended December 31, 2024, ...
BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)
BX211 was safe and well-toleratedBX211 produced sustained and statistically significant1 Percent Area Reduction (PAR) of ulcer size (p = 0.046 at ...
CAMARA, the Global Telco API Alliance, Unveils its Spring25 Meta-Release: Cutting-Edge APIs for Seamless Network Functions Access
The Linux Foundation's CAMARA project, an open source community addressing telco industry API interoperability, today announced the availability of its second official release, CAMARA "Meta-release ...
carguide.ph52m
Hyundai Opens In Palawan
First operating in 2013, the dealer group curated its diverse business portfolio with a history of involvement in real estate, pharmaceuticals, the automotive industry, fast-moving consumer goods, and ...